Lifecore Biomedical, Inc. De (LFCR) Other Accumulated Expenses (2011 - 2024)

Lifecore Biomedical's Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $9.9 million for Q4 2024.

• In Q4 2024, Other Accumulated Expenses rose 28.85% year-over-year to $9.9 million; the TTM figure through Nov 2024 stood at $9.9 million (up 28.85% YoY), while the FY2024 annual figure was $9.4 million, up 30.97% from the prior year.
• Other Accumulated Expenses was $9.9 million for Q4 2024 at Lifecore Biomedical, down from $11.4 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $13.0 million in Q1 2022 to a low of $3.0 million in Q2 2021.
• Historically, Other Accumulated Expenses has averaged $7.7 million across 5 years, with a median of $7.4 million in 2023.
• The sharpest annual moves came in 2020 and 2021: Other Accumulated Expenses jumped 389.98% in 2020, then plunged 69.84% in 2021.
• A 5-year view of Other Accumulated Expenses shows it stood at $6.1 million in 2020, then sank by 36.55% to $3.9 million in 2021, then jumped by 141.37% to $9.4 million in 2022, then fell by 18.24% to $7.7 million in 2023, then increased by 28.85% to $9.9 million in 2024.
• The last three Other Accumulated Expenses figures came in at $9.9 million (Q4 2024), $11.4 million (Q3 2024), and $9.4 million (Q2 2024), per Business Quant data.